Monitor for any conversion of this 13G to a 13D, which would signal activist intent. The simultaneous presence of multiple 13G filers (ADAR1, BVF, Trails Edge) suggests coordinated institutional accumulation — watch for pipeline catalysts or M&A speculation that could trigger a 13D filing.
Price Chart
Executive Summary
Coastlands Capital LP filed a new Schedule 13G disclosing a 6.67% passive stake in OnKure Therapeutics, holding 2,700,000 shares of Class A Common Stock. This is a new position for Coastlands, which joins three other institutional filers (ADAR1 Capital, Biotechnology Value Fund, Trails Edge Capital) that previously reported 13G amendments on the same date. The passive filing indicates no intent to influence management, but the concentration of multiple 13G filers signals notable institutional interest in OKUR.
Key Financial Metrics
Key Facts
- Coastlands Capital LP disclosed a 6.67% passive stake in OnKure Therapeutics, holding 2,700,000 shares.
- Stake is held directly by Coastlands Capital Partners LP; beneficial ownership attributed to Coastlands Capital LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry.
- Filing is a new Schedule 13G (not an amendment), dated October 7, 2026.
- Based on 40,496,309 shares outstanding as of August 3, 2026 (per issuer's 10-Q).
- Excludes pre-funded warrants held in excess of a 4.99% beneficial ownership limitation.
- Three other institutions (ADAR1 Capital, Biotechnology Value Fund, Trails Edge Capital) filed 13G amendments on August 14, 2026, indicating prior passive positions.
Financial Impact
6.67% passive stake valued at approximately $2.7M based on 2.7M shares; no transaction price disclosed.
Risk Factors
- Passive 13G status could convert to activist 13D if Coastlands seeks board representation or strategic changes.
- Pre-funded warrant overhang (excluded due to 4.99% cap) could be exercised, increasing dilution risk.
- Biotech sector volatility and clinical-stage risk for OnKure's pipeline.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-114447 |
| Document: 0001104659-26-114447-index-headers.html | 0001104659-26-114447 |
| Document: 0001104659-26-114447-index.html | 0001104659-26-114447 |
| Document: 0001104659-26-114447.txt | 0001104659-26-114447 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G | $2.30 | awaiting T+60 | — | $2.52 (+9.57%) |
Aug 4, 2026 11w ago | 8-K | $4.16 | awaiting T+60 | — | $2.52 (−39.42%) |
Apr 24, 2026 26w ago | S-3 | $4.99 $4.32 | ▲ +13.43% | ▲ +18.20% | $2.52 (+49.50%) |
Apr 21, 2026 26w ago | DEFA14A | $5.01 $4.20 | ▼ −16.17% | ▼ −20.95% | $2.52 (−49.70%) |
Mar 23, 2026 31w ago | Insider Cluster | $3.98 $4.29 | ▲ +7.79% | ▼ −5.27% | $2.52 (−36.68%) |
Mar 12, 2026 32w ago | Press Release | $3.78 $4.40 | ▲ +16.40% | ▲ +4.79% | $2.52 (−33.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers